Medical Cell Biology Commons^™

Suppression Of Human Coronavirus 229e Infection In Lung Fibroblast Cells Via Rna Interference, Hamidreza Montazeri Aliabadi, Jennifer Totonchy, Parvin Mahdipoor, Keykavous Parang, Hasan Uludağ

Pharmacy Faculty Articles and Research

Despite extensive efforts to repurpose approved drugs, discover new small molecules, and develop vaccines, COVID-19 pandemic is still claiming victims around the world. The current arsenal of antiviral compounds did not perform well in the past viral infections (e.g., SARS), which casts a shadow of doubt for use against the new SARS-CoV-2. Vaccines should offer the ultimate protection; however, there is limited information about the longevity of the generated immunity and the protection against possible mutations. This study uses Human Coronavirus 229E as a model coronavirus to test the hypothesis that effective delivery of virus-specific siRNAs to infected cells will …

Development Of An Immunoblot To Detect Human Antibodies Against Sars-Cov-2 Virus Proteins, Shivum Desai

Honors Theses

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a virus that infects cells in the lungs, nasal passages, and intestines via the ACE2 receptors of the host, and leads to the coronavirus disease (COVID-19). Since the occurrence of the pandemic in December 2019, there have been 114 million cases worldwide in which 2.5 million lives have unfortunately been taken away.

Being diagnosed with a past infection stems questions among those that have tested positive through antibody testing. The problem here is that patients were notified that they have antibodies resulting from a SARS-CoV-2 infection, but in fact they may not …